HP and diabetes mellitus: Our systematic review suggests that drug-genetic interactions between vitamin E and the Hp genotype may be achieved partly by improving the biological function of HDL in DM, which supports the hypothesis that individuals with a high CVD risk carrying the Hp2-2 genotype may benefit from vitamin E therapy.